The dilution story SGA panders to the world is a crock for a number of reasons. Medafor pays their attorneys with hard cold cash. This whole subject brings into question the integrity of SGA, but that is a story for another time and place.
For CY 2010, Medafor has roughly $6M cash flow to fight CRY and grow sales.
Next year close to $9M plus to do the same thing.
SGA is still playing the muscle game with Medafor. It may, or may not, work. However SGA is fighting the cash flow clock, and that swings slowly in Medafor's favor.
On the flip side, I think CRY has a decent shot at an emergency injunction, but since I'm not an attorney I could easily be wrong.